EchoGo Amyloidosis vs Study Watch
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is an AI-powered diagnostic aid specifically designed to screen for cardiac amyloidosis using echocardiogram video clips. Tool B is a wearable device for continuous physiological monitoring, collecting data like ECG and heart rate primarily for clinical research and broader precision health solutions. While both utilize AI in cardiology and are FDA-cleared, Tool A offers a targeted diagnostic output for a specific condition, whereas Tool B provides a platform for data collection and analysis for a wider range of monitoring and research applications.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Amyloidosis is an AI-powered screening tool designed to aid in the early detection of cardiac amyloidosis by analyzing echocardiogram video clips. Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement.
EchoGo Amyloidosis offers seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7, as a cloud-based SaaS model. Study Watch is a wearable device that collects data and uploads it to Verily's cloud platform for processing with algorithms and machine learning.
For EchoGo Amyloidosis, there are specific reimbursement codes: NTAP Code ICD-10 XXE2X19 for inpatient analysis ($1,000, Medicare-covered) and HCPCS Code C9786 (or CPT code 0932T as of January 1, 2025) for outpatient analysis ($285, covered by Medicare and select commercial insurers). Study Watch's pricing is not publicly available as it is a device for clinical research and partnerships.
EchoGo Amyloidosis analyzes echocardiogram video clips to assess echocardiographic markers such as ventricular volume, cardiac function, and myocardial movement, providing a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis. Study Watch collects continuous physiological data from multiple sensors, including ECG, heart rate, electrodermal activity, and inertial movements, for analysis in Verily's cloud platform.
EchoGo Amyloidosis boasts high diagnostic accuracy for cardiac amyloidosis, with 85% sensitivity and 93% specificity, and consistent performance across CA subtypes (AL, wild-type ATTR, variant ATTR). Study Watch is a data collection device for clinical research, and while it provides on-demand single-channel ECG and irregular pulse monitoring, specific diagnostic accuracy metrics for conditions are not provided for the device itself.